Analysts/Institutional Investor Meet/Con. Call Updates

Date: 10th September, 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051. Security Code:532815 Symbol: SMSPHARMA Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Schedule of Analyst / Institutional Investors Meeting Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform that the Company’s management will be participating in the following group analyst/ investor meeting(s): Date of meeting Venue Nature of the Interaction with Analyst/Institutional Meeting Investor 15 September Hyderabad Group meet Emkay Global Investors Meeting 2026 Kindly note the following: • The above schedule is subject to changes and the changes may happen due to exigencies on the part of the Analyst(s)/ Investor(s)/ the Company. • The discussion with Analysts/Institutional Investors during meeting would be based on Industry/ Company specific developments already in public domain and no unpublished price sensitive information pertaining to the Company will be shared during the meet. Kindly take the above documents on record. Thanking you Yours faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary